Mohamad Mohty Selected Research

Mohamad Mohty Research Topics

Disease

201	Leukemia 05/2024 - 08/2003
199	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 08/2003
115	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 07/2003
68	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 07/2002
62	Multiple Myeloma 11/2023 - 03/2008
53	Neoplasms (Cancer) 01/2024 - 07/2002
40	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2003
23	Pathologic Complete Response 05/2024 - 05/2008
18	Bronchiolitis Obliterans Syndrome 10/2023 - 11/2002
17	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 12/2012
17	Lymphoma (Lymphomas) 10/2022 - 05/2008
15	Residual Neoplasm 12/2023 - 02/2010
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2012
11	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 02/2011
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 09/2008
10	Hematologic Diseases (Blood Diseases) 12/2023 - 02/2012
10	Infections 01/2021 - 11/2010
9	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2023 - 10/2016
9	COVID-19 01/2023 - 01/2020
9	Disease Progression 10/2021 - 07/2011
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 12/2019
8	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 10/2010
8	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 02/2013
7	Philadelphia Chromosome 01/2023 - 03/2015
5	Fibrosis (Cirrhosis) 01/2022 - 01/2011
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 07/2011
4	Cytopenia 01/2024 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 01/2010
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2019
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2021 - 11/2012
4	Aplastic Anemia (Anemia, Hypoplastic) 10/2019 - 10/2013
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016 - 07/2002
4	Peripheral Nervous System Diseases (PNS Diseases) 03/2012 - 06/2008
3	Dysbiosis 11/2023 - 01/2021
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2016
3	Neutropenia 10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

74	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 10/2013
39	Busulfan (Busulfex)FDA Link 11/2023 - 07/2003
37	fludarabineIBA 02/2024 - 07/2003
36	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2024 - 07/2003
19	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2023 - 01/2016
16	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2010
13	Melphalan (Alkeran)FDA LinkGeneric 12/2023 - 04/2015
12	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2019
12	Bortezomib (Velcade)FDA Link 01/2023 - 03/2008
10	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 01/2010
10	treosulfanIBA 02/2024 - 08/2012
10	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 11/2010
8	Proteasome InhibitorsIBA 01/2023 - 06/2008
8	Lenalidomide (CC 5013)FDA Link 01/2022 - 02/2012
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024 - 03/2016
7	AntigensIBA 04/2024 - 02/2011
7	SteroidsIBA 08/2023 - 09/2009
7	defibrotideIBA 05/2023 - 10/2016
7	plerixafor FDA Link 03/2023 - 11/2012
7	Clofarabine (Clolar)FDA Link 01/2023 - 09/2012
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2015
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 11/2012
6	Methotrexate (Mexate)FDA LinkGeneric 04/2024 - 10/2006
6	thymoglobulin FDA Link 12/2023 - 12/2010
6	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 11/2008
6	Immunomodulating AgentsIBA 01/2023 - 12/2013
6	tisagenlecleucelIBA 10/2022 - 01/2019
6	Monoclonal AntibodiesIBA 01/2022 - 09/2009
6	fms-Like Tyrosine Kinase 3IBA 01/2022 - 08/2017
6	Thalidomide (Thalomid)FDA Link 10/2021 - 02/2010
6	Imatinib Mesylate (Gleevec)FDA Link 12/2015 - 06/2004
5	Calcineurin InhibitorsIBA 04/2024 - 03/2016
5	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 01/2018
5	carfilzomibIBA 01/2023 - 01/2019
5	Rituximab (Mabthera)FDA Link 09/2020 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2008
4	axicabtagene ciloleucelIBA 10/2022 - 12/2019
4	daratumumabIBA 01/2022 - 11/2019
4	VaccinesIBA 12/2021 - 07/2002
4	eculizumab FDA Link 01/2021 - 11/2012
4	Gemtuzumab (Mylotarg)FDA Link 12/2020 - 11/2008
4	CytokinesIBA 11/2020 - 12/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 10/2006
4	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 12/2012
4	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 08/2017
3	Core Binding Factors (Core-Binding Factor)IBA 04/2024 - 01/2020
3	AntibodiesIBA 01/2024 - 01/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023 - 12/2019
3	isatuximabIBA 01/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2016

Therapy/Procedure

209	Transplantation 05/2024 - 11/2002
183	Stem Cell Transplantation 05/2024 - 11/2002
116	Hematopoietic Stem Cell Transplantation 03/2024 - 05/2008
106	Cell Transplantation 04/2024 - 10/2011
87	Therapeutics 01/2024 - 09/2005
45	Drug Therapy (Chemotherapy) 03/2024 - 08/2003
25	Haploidentical Transplantation 05/2024 - 04/2015
22	Homologous Transplantation 04/2024 - 07/2003
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 04/2012
10	Autologous Transplantation 01/2023 - 11/2008
10	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 12/2022 - 11/2004
9	Immunotherapy 01/2022 - 07/2002
7	Salvage Therapy 01/2019 - 10/2006
3	Fecal Microbiota Transplantation 12/2023 - 01/2019